The coronavirus disease 2019 (COVID-19)
primarily affects the respiratory system, however, the clinical presentation of
patients is usually multi-systemic due to the immunologic response to the
virus. Neuropsychiatric symptoms occur in one-third of patients during the
acute phase of the infection and represent initial symptoms in a small number
of patients. The exact mechanism by which COVID-19 causes Neuropsychiatric
symptoms is not fully understood, however, researchers have suggested the roles
of the hyperactive immune response and the affinity of the virus to some
receptors in the brain, among other possibilities. There are pathognomonic
neuropsychiatric symptoms specific to COVID-19, nevertheless, commonly reported
and/or observed presentations include, delirium, anxiousness, depression and
sleep problems. The majority of patients have mild to moderate symptom severity
with optimal response to short-course of appropriate psychotropic medications
and other psychosocial interventions.
Author(s)
Details:
Ejike
Chukwuma Nwokwor
Department of Psychiatry, Missouri University
Hospital, Columbia MO, USA.
Muhammad
Gidado Ibrahim
Department of Psychiatry, Barau Dikko Teaching
Hospital, Kaduna, Nigeria.
Please see the book here: https://doi.org/10.9734/bpi/mono/978-81-973195-5-6/CH19
No comments:
Post a Comment